MARSHALL WACE, LLP - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2022$355,000
-53.2%
634,236
-6.4%
0.00%0.0%
Q1 2022$759,000
-41.7%
677,866
-24.0%
0.00%
-50.0%
Q4 2021$1,303,000
+249.3%
891,977
+618.7%
0.00%0.0%
Q3 2021$373,000
+100.5%
124,117
+210.7%
0.00%
+100.0%
Q2 2021$186,000
+210.0%
39,942
+284.4%
0.00%0.0%
Q1 2020$60,000
-88.5%
10,392
-85.6%
0.00%
-75.0%
Q4 2019$520,000
+125.1%
72,076
+90.6%
0.00%
+100.0%
Q3 2019$231,00037,8210.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders